MAPT and early-onset autosomal dominant Alzheimer disease: We treated DnaJC7 and DnaJB6 KO cell lines with either recombinant tau fibrils or brain lysates from subjects with Alzheimer’s Disease (AD), Progressive Supranuclear Palsy (PSP), or Corticobasal Degeneration (CBD).